Prime Therapeutics LLC (Prime), a pharmacy benefit manager (PBM) serving more than 28 million Blue Cross and Blue Shield members nationally, recently studied its NetResults™ formulary – a...

Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States, subsidiary Phyto Animal Health today announced that it will exhibit at the NoCo Hemp Expo...

Lattice Engines, the world's first & largest B2B Customer Data Platform, announced today that it had turned cash-flow positive in early 2019. Building upon the momentum of a strong 2018, the...

Spring Labs, which is developing the Spring Protocol, a network designed to transform how information and data are shared globally, announces today that CEO Adam Jiwan will be speaking at the...

A real-world study by pharmacy benefit manager (PBM) Prime Therapeutics LLC (Prime), found while most Botox® (onabotulinumToxinA) use is for chronic migraine prevention at an annual cost of more than